The observed STAT3 activation in GDM placental cells treated with adipose tissue-derived EVs may contribute to insulin resistance and inflammation within the placenta, impacting placental function and nutrient transport to the fetus in GDM [62]. The gene discussed is STAT3; the disease is gestational diabetes.